Insulin Glargine vs Osimertinib
Insulin Glargine vs Osimertinib: Overview
This comparison examines the pharmacological differences between Insulin Glargine and Osimertinib.
Mechanism of Action
Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Insulin Glargine β 12-24 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2.
Molecular Weight: Osimertinib β 499.6050 g/mol.
Type: Insulin Glargine β Protein; Osimertinib β Small molecule.